Biological Keepsakes: Clinical Risks and Regulatory Gaps in Tissue Retention

The intersection of patient autonomy and clinical safety is reaching a new flashpoint as more individuals request the return of biological materials following medical procedures. While the retention of baby teeth has long been a cultural norm, the scope of these requests has expanded to include placentas for consumption, gallstones, and even skeletal remains like kneecaps for use in jewelry. This shift represents a significant challenge for healthcare providers who must balance a patient’s perceived right to their own biological 'property' against the stringent requirements of biohazard management and public health safety.

At the center of this debate is the practice of placentophagy, or the consumption of the placenta. Proponents often claim that consuming the organ—whether raw, cooked, or encapsulated—can prevent postpartum depression, improve energy levels, and boost milk production. However, the clinical reality paints a different picture. There is currently no robust scientific evidence to support these therapeutic claims. Conversely, the risks are well-documented. The placenta acts as a filter during pregnancy, potentially accumulating heavy metals and harboring dangerous pathogens. In 2017, the Centers for Disease Control and Prevention (CDC) issued a stark warning after a newborn developed late-onset Group B Streptococcus (GBS) sepsis linked to the mother consuming contaminated placenta capsules. This incident highlighted the lack of regulation in the placental encapsulation industry, where processing temperatures often fail to reach the levels necessary to eradicate heat-resistant pathogens.

“

In 2017, the Centers for Disease Control and Prevention (CDC) issued a stark warning after a newborn developed late-onset Group B Streptococcus (GBS) sepsis linked to the mother consuming contaminated placenta capsules.

Beyond consumption, the trend of 'bio-jewelry'—turning teeth, hair, or bone into wearable keepsakes—introduces a different set of regulatory hurdles. When a hospital releases human tissue to a patient, it effectively transfers a biohazard from a controlled environment to an unregulated one. Most domestic settings lack the sterilization equipment required to render human tissue inert. If bone or tissue is not properly preserved, it can become a breeding ground for bacteria, posing a long-term health risk to the owner and the public. Furthermore, the legal classification of these materials remains murky. While some jurisdictions view non-pathological tissue as the property of the patient, others classify any removed human matter as clinical waste that must be incinerated by law. This inconsistency leaves hospitals vulnerable to litigation and creates confusion for surgical teams.